Our finding that patients with CHMP2B-FTD show a distinct pattern of disruption of the microstate D is in accordance with a frontoparietal dysfunction presenting as the clinical feature of reduced executive function. The gene discussed is CHMP2B; the disease is frontotemporal dementia.